血液性恶性瘤患者治疗前的生活质量与存活率之间的关系:元分析
Keiichi Osaki1, Shinichiro Morishita2, Jiro Nakano3
1Department of Rehabilitation, Panasonic Health Insurance Organization, Matsushita Memorial Hospital.
Fukushima journal of medical science
|February 5, 2025
概括
治疗前的生活质量 (QoL) 对血液性恶性瘤患者的整体存活率 (OS) 有显著影响. 全球,物理和社会QOL维度显示,在化学疗法和干细胞移植等治疗中,与OS有积极的关联.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 生活质量研究 研究 生命质量研究
背景情况:
- 生活质量 (QoL) 越来越被认为是患者结果的关键因素.
- 了解预治疗QOL和整体存活率 (OS) 之间的关系对于管理血液性恶性瘤至关重要.
研究的目的:
- 进行一项元分析,调查治疗前生活质量 (QoL) 对血液性恶性瘤患者的整体存活时间 (OS) 的影响.
- 探索QoL和OS之间的关联,根据包括血造干细胞移植 (HSCT) 和化疗在内的治疗方式分层.
主要方法:
- 对观察性研究进行了系统的元分析,检查了QoL和OS之间的联系.
- 研究包括接受HSCT或血液恶性瘤化疗的患者.
- 数据按治疗类型分层,以分析特定的关联.
主要成果:
- 总体来看,OS与全球QOL (HR=1.04),物理QOL (HR=1.06) 和社会QOL (HR=1.02) 之间存在显著的关联.
- 在HSCT患者中,分层揭示了OS和全球QoL (HR=1.05) 和物理QoL (HR=1.03) 之间的显著联系.
- 化疗患者显示了OS和全球QoL (HR=1.04),物理QoL (HR=1.08),角色QoL (HR=1.02) 和社会QoL (HR=1.02) 之间的显著关联.
- 在有限的HSCT分析中,情绪QoL与OS没有显著的关联.
结论:
- 治疗前的QoL维度,特别是全球,物理和社会方面,是血液恶性瘤中OS的重要预测因素.
- QoL 对 OS 的影响取决于治疗方式 (HSCT 与化疗).
- 评估治疗前的 QoL 对于预后评估和血液癌症个性化治疗策略至关重要.
相关概念视频
01:21Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
01:20Comparing the Survival Analysis of Two or More Groups
131
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
131
01:20Actuarial Approach
57
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
57
01:24Kaplan-Meier Approach
80
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
80
01:15Assumptions of Survival Analysis
85
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
85
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K